# Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute Ischemic Stroke

> **NCT05367362** · PHASE2 · WITHDRAWN · sponsor: **State University of New York at Buffalo**

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Minocyclin

## Key facts

- **NCT ID:** NCT05367362
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-12-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study never started, no participants enrolled due to lack of funding
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05367362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05367362, "Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute Ischemic Stroke". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05367362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*